Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Longeveron (LGVN)

Longeveron Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LGVN
DateTimeSourceHeadlineSymbolCompany
05/03/202514:25GlobeNewswire Inc.Longeveron® to Present at the 37th Annual Roth ConferenceNASDAQ:LGVNLongeveron Inc
28/02/202521:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LGVNLongeveron Inc
28/02/202521:04GlobeNewswire Inc.Longeveron® Announces Full-Year 2024 Financial Results and Provides Business UpdateNASDAQ:LGVNLongeveron Inc
28/02/202521:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LGVNLongeveron Inc
21/02/202513:30GlobeNewswire Inc.Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025NASDAQ:LGVNLongeveron Inc
18/02/202514:25GlobeNewswire Inc.Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™NASDAQ:LGVNLongeveron Inc
30/01/202521:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LGVNLongeveron Inc
07/01/202500:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
07/01/202500:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
07/01/202500:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
07/01/202500:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
18/12/202414:10GlobeNewswire Inc.Longeveron to Present at Biotech Showcase 2025NASDAQ:LGVNLongeveron Inc
12/11/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LGVNLongeveron Inc
12/11/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LGVNLongeveron Inc
12/11/202421:05GlobeNewswire Inc.Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LGVNLongeveron Inc
11/11/202414:05GlobeNewswire Inc.Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)NASDAQ:LGVNLongeveron Inc
04/11/202421:05GlobeNewswire Inc.Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024NASDAQ:LGVNLongeveron Inc
29/10/202414:00GlobeNewswire Inc.Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)NASDAQ:LGVNLongeveron Inc
27/10/202419:10GlobeNewswire Inc.Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual MeetingNASDAQ:LGVNLongeveron Inc
14/10/202413:05GlobeNewswire Inc.Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)NASDAQ:LGVNLongeveron Inc
09/10/202413:05GlobeNewswire Inc.Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual MeetingNASDAQ:LGVNLongeveron Inc
07/10/202413:05GlobeNewswire Inc.Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy DayNASDAQ:LGVNLongeveron Inc
03/10/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
03/10/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
03/10/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
03/10/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
02/10/202413:05GlobeNewswire Inc.Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceNASDAQ:LGVNLongeveron Inc
26/09/202413:05GlobeNewswire Inc.Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the MesaNASDAQ:LGVNLongeveron Inc
03/09/202413:00GlobeNewswire Inc.Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS)NASDAQ:LGVNLongeveron Inc
26/08/202420:05GlobeNewswire Inc.Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:LGVNLongeveron Inc
 Showing the most relevant articles for your search:NASDAQ:LGVN